Case Study: Biohaven Pharmaceuticals achieves control of SOX and SEC reporting with Workiva

Biohaven Pharmaceuticals Takes Control of SOX, SEC Reporting

Biohaven Pharmaceuticals, a rapidly growing biotech that went public in 2017, faced mounting demands on a small finance team responsible for SEC reporting, SOX compliance, investor relations, and internal controls. The company needed better version control, workflow structure, and cross‑functional collaboration to manage growing regulatory and reporting complexity.

Biohaven adopted the Workiva cloud platform for SEC reporting and expanded its use to SOX, investor relations, and other business processes. The platform added structured, automated workflows, granular permissions, and real‑time collaboration for a largely remote team—delivering faster report turnaround, stronger control over compliance and reporting, and a scalable solution that grows with the company.

Biohaven Pharmaceuticals

George Clark

Head of SEC Reporting and Technical Accounting